Delivery Order SPE2DB22D1106-SPE2DB25FEKG0
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,406.58 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pen (0.5ml), a diabetes medication. The contract was awarded on a firm fixed-price basis without a set-aside designation, with an ultimate completion date of June 3, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $4,477.80 to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pen 0.5 mL, a diabetes medication, on May 12, 2025, with an ultimate completion date of May 13, 2025. The contract employs firm fixed-price pricing under a competitive, non-set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, served as the awardee with performance occurring at its corporate office location in Conshohocken, PA...
- The Defense Logistics Agency awarded a delivery order valued at $1,949.85 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens (0.5 ml units), a diabetes medication. This competitively awarded, firm fixed-price delivery order was issued on August 27, 2025, with an ultimate completion date of August 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,501.50 to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 ml pen 0.5ml, a diabetes medication. This is a firm fixed price, non-competitive delivery order under an Indefinite Delivery Contract (IDC) with a completion date of September 18, 2025. The vendor, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,154.16 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens (0.5 ml units), a diabetes medication. This non-competitive delivery order, issued on May 30, 2025, with an ultimate completion date of June 2, 2025, was awarded under firm fixed pricing terms. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfills this order from its corporate office location in the same city. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,359.82 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens (0.5 ml), a diabetes medication. The contract was executed as a firm fixed price delivery order on June 25, 2025, with an ultimate completion date of June 26, 2025, and involves no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,663.27 for Trulicity 1.5 mg/0.5 ml pen 0.5ml, a diabetes medication, with an ultimate completion date of August 13, 2025. This non-competitive, firm fixed-price delivery order was awarded on August 12, 2025, with performance to be executed at the vendor's location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's broader pharmaceutical supply...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,951.95 for Trulicity 1.5 mg/0.5 ml pen (0.5 ml), a diabetes medication. The contract was awarded on August 15, 2025, with an ultimate completion date of August 18, 2025, and represents a firm fixed-price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,674.49 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pen (0.5 ml), a diabetes medication. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and was executed on August 27, 2025, with an ultimate completion date of August 28, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters and primary...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,562.69 for Trulicity 1.5 mg/0.5 ml pen (0.5 ml), a diabetes medication. This non-set-aside, firm fixed price delivery order was awarded on July 23, 2025, with an ultimate completion date of July 24, 2025. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEKG0Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,254.39 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pen (0.5 ml), a diabetes medication. The contract was awarded on April 23, 2025, with an ultimate completion date of April 24, 2025, and utilizes firm fixed-price pricing with no set-aside designation. The pharmaceutical products will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle valued through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The DLA Troop Support Medical IDC enables the company to supply an extensive range of pharmaceutical products, medical devices, vaccines, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare programs worldwide. This contract reflects AmerisourceBergen's capability to fulfill federal procurement requirements through competitive selection, with the company positioned to serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems under this flexible contracting vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 4/23/25 |